Approximately half of men with metastatic castration-resistant prostate cancer and BRCA1 or BRCA2 mutations do not receive medications that could improve their survival.Poly (adenosine ...

Once E3 tags CYP17A1, the cell uses its proteasome to break down the enzyme entirely. One major advantage of PROTACs is that ...

A multicenter clinical study in Austria has shown that a new, highly precise ultrasound approach can successfully target and ...

Oncologists and urologists identified several barriers to treatment intensification for metastatic castration-sensitive ...

Turmeric, a golden spice, offers potent antioxidant and anti-inflammatory benefits through its compound curcumin. However, ...

Despite massive advancements in Cancer treatment in the last few decades, Cancer still remains one of the most fatal ...

Dr. Kurt N. Ransohoff, President, Sutter Health Greater Central Coast, moderated the multidisciplinary panel of six ...

Dr. Sunitha N of Vasavi Hospitals highlights how daily dietary choices significantly impact cancer risk. Emphasizing ...

The addition of a Lactobacillus probiotic supplement to the phytochemical-rich food supplement significantly improved rate of PSA progression from 23.2% to -21.4% (44.6% change, P 0.001), compared to ...

Prostate cancer often earns the label “silent killer” because it can develop and progress for years without producing noticeable symptoms. Understanding this timeline becomes crucial for men seeking ...

The UK’s approach to prostate cancer is failing men from pre-diagnosis through to advanced disease management, according to new reports. Experts cite three critical failings: the lack of a screening ...

A newly uncovered mechanism thought to be a weakness of prostate cancer cells could inspire a new and improved targeted treatment for the disease. International research led by Flinders University in ...